Clinical Trials
2 trialsNCT06566209 2026-05-08
FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis
Mayo Clinic
Terminated
NCT03057743 2021-11-18
Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer
Abramson Cancer Center at Penn Medicine
Terminated